Engagement Methods for Community Involvement
(PRECIDENTD-EMS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether different ways of engaging with patients and study staff can improve outcomes in an ongoing diabetes study. It compares a new method called "agile engagement" (an agile methods engagement approach) to a standard approach to determine which better boosts research results, such as patient recruitment and medication adherence in the main diabetes trial. The study also examines whether these engagement methods lead to better cooperation and satisfaction among participants. Potential participants include those already involved as advisors or staff in the main diabetes study. As an unphased trial, this study offers participants the opportunity to contribute to innovative research methods that could enhance diabetes care and patient engagement.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on engagement methods rather than medication changes.
What prior data suggests that these engagement methods are safe for stakeholders?
In a previous study, participants using Agile methods reported feeling safe and supported. This feeling, known as psychological safety, means they were comfortable sharing ideas and concerns without fear of negative consequences. Another study found that Agile methods in healthcare led to positive experiences, with patients feeling more independent and less anxious.
These findings suggest that Agile methods are well-tolerated. The studies reported no specific negative effects, indicating that the approach appears safe. There is no direct evidence of harm from using Agile methods in engagement.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores different methods to boost community involvement through engagement approaches. Unlike standard methods that may use traditional communication and outreach strategies, the experimental "Agile methods engagement approach" aims to be more dynamic and responsive. This approach could lead to higher participation and more effective community involvement by adapting quickly to feedback and changing needs. By testing these methods, researchers hope to discover more efficient ways to engage communities, which could be transformative for future projects and initiatives.
What evidence suggests that this trial's engagement methods could be effective?
This trial will compare the Agile methods engagement approach with the Standard engagement approach. Studies have shown that flexible methods, like those in the Agile approach, can enhance collaboration and goal achievement. Research indicates that involving everyone in planning and working collaboratively leads to better teamwork and communication. A review of studies found that flexible leadership improves efficiency and effectiveness. These methods foster a more engaged and committed team, potentially leading to better study outcomes, such as improved participant recruitment and medication adherence in trials.678910
Are You a Good Fit for This Trial?
This trial is for sites involved in the PRECIDENTD study, which focuses on preventing major health events in type 2 diabetes patients. It's not for individual patients but for research sites looking to improve engagement with stakeholders.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Engagement Methods Evaluation
Evaluation of agile versus standard engagement methods at study sites
Follow-up
Participants are monitored for research outcomes, engagement quality, and partner outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Agile methods engagement approach
- Standard engagement approach
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator
Brigham and Women's Hospital
Collaborator